Welcome to the Internal Medicine Intern Teaching Conference Series
|
|
|
- Augustus Watson
- 10 years ago
- Views:
Transcription
1 Welcome to the Internal Medicine Intern Teaching Conference Series Melissa (Moe) Hagman, MD, FACP University of Washington Internal Medicine & Palliative Care pager
2 Intern Teaching Conferences Objectives Provide information on topics of importance to new medicine interns Provide a forum for interns to share insights & questions regarding patient care
3 Intern Teaching Conferences AM Thursday Conferences July 1 August 5, UWMC Interns Report HMC Thursday 11:30am-12:30pm SVAMC Thursday noon-1pm UW Friday noon-1pm ***Please provide feedback***
4 Intern Teaching Conference What to Do When You Are Called to See a Patient with Pain July 1, 2010
5 Choosing a Pain Medication Flavor, dose, route, interval
6 Ms. M RN calls to report that Ms. M is having 10/10 right hip pain Acetaminophen 500mg po q6hrs prn is not working
7 Ms. M Sign-out 75 yo woman Full code Fall from standing with R hip fracture; to OR in AM for repair by Orthopedics Meds dalteparin, acetaminophen NTD Avoid CNS active medications due to risk of delirium
8 Ms. M Hx pain indeed appears to be from hip fracture PE Afeb, BP 156/92, HR 88, RR 16, O2 sat 97%RA AOx4, can parrot sequences of numbers up to 5 in a row forward Allergies NKDA
9 What order would you write to try to improve Ms. M s pain control? 1. Add ibuprophen 600mg poq8hrs prn pain 2. d/c acetaminophen & start percocet 5/325mg poq4hrs prn pain 3. Add oxycodone 2.5-5mg poq4hrs prn pain 4. Add morphine 1-2mg IV q4hrs prn pain 25% 25% 25% 25%
10 World Health Organization s Stepwise Analgesia Ladder Step Pain Drug I Mild Non-opioid (acetaminophen, NSAIDS) II Moderate Non-opioid plus weak opioid (hydrocodone, codeine, oxycodone) III Severe Non-opioid plus strong opioid (morphine, hydromorphone, fentanyl, etc.) AAHPM. UNIPAC Series: Hospice/Palliative Care Training for Physicians
11 Non-Opioid Analgesia Acetaminophen and/or NSAIDs can augment the pain relief provided by narcotics Consider scheduled acetaminophen Avoid NSAIDs in the elderly all together Renal failure, CHF, GIB Careful with inpatient NSAIDS in general Renal failure (especially if volume depletion) GI bleeding risk Other bleeding risk (including surgical)
12 Non-Opioid Analgesia Caution when using combination pills Acetaminophen is most common cause of acute liver failure in United States Patients forget that acetaminophen is present in many OTC medications No more than 4000 mg acetaminophen/day Consider prescribing acetaminophen and/or NSAIDs separately
13 Initiating Narcotics In renal insufficiency: methadone and fentanyl optimal oxycodone and hydromorphone with caution AVOID morphine and codeine In hepatic insufficiency: fentanyl, hydromorphone, oxycodone, and methadone with caution AVOID morphine Avoid use of meperidine because of risk of seizure in most situations
14 Ms. M Schedule acetaminophen 1000mg po QID (or q6hrs if you want her woken up) Max 4000mg a day For elderly, start narcotics at half usual starting dose and follow closely Oxycodone 2.5-5mg po q4hrs prn pain
15 If oral oxycodone not effective or you want an IV narcotic, what order would you write for Ms. M? 1. Morphine 1-2mg IV q4hrs prn pain 2. Morphine 0.5mg IV q4hrs prn pain 3. Hydromorphone 1-2mg IV q4hrs prn pain 4. Hydromorphone 0.2mg IV qhrs prn pain 25% 25% 25% 25%
16 Narcotic Equianalgesic Doses Drug PO IV Morphine 30 mg 10 mg Oxycodone 20 mg --- Hydromorphone 7.5 mg 1.5 mg Hydrocodone 30 mg mg morphine IV 0.15 mg hydromorphone IV 1.5 mg hydromorphone IV = X 10mg MS IV 1mg MS IV
17 Ms. M 3 Days Later Ms. M is POD#2 for surgical repair of hip Now complains of abdominal pain and no BM for 4 days.
18 Initiating Narcotics Always consider prophylactic medications to prevent constipation Docusate 250 mg po bid Senna 2 tabs po qhs others If concern for prior narcotic-induced nausea give an antiemetic with the narcotic for approximately 3 days until tolerance to nausea side effect has developed
19 Mr. G RN calls to report that Mr. G is having 9/10 back pain Acetaminophen 1000mg PR qid and morphine 1-2 mg IV q4hrs are not working
20 Mr. G Sign-out 73 yo gentleman Metastatic prostate cancer on hormonal therapy; receiving XRT to spine Admitted with nausea/vomiting (thought to be partial SBO) and renal failure Meds acetaminophen, morphine, antiemetic, bisacodyl PR, IVF NTD
21 You go see Mr. G: Mr. G complains of baseline diffuse bony discomfort relieved by acetaminophen and morphine ER 60 mg po q 12hr + morphine IR two 15 mg tabs/day feels like he is not getting enough pain medication since switched from home pills to IV meds in hospital Should he continue morphine? What can we do for his pain?
22 Narcotic Conversions Morphine ER 60 mg po q 12hr + morphine IR two 15 mg tabs/day = 120 mg + 30 mg = 150 mg total/day Decrease dose by 1/3 rd to half for incomplete cross tolerance when changing narcotics 150 mg/day x 2/3 = 100 mg/day morphine (to convert to fentanyl)
23 Narcotic Conversion to Fentanyl Oral Morphine/24hr Initial Fentanyl Patch 90 mg 25 mcg/hr 180 mg 50 mcg/hr 360 mg 75 mcg/hr 100 mg/day morphine dose patches q72hrs full dose onset 12hrs
24 Now that fentanyl patch in place, what order would you write for break through pain for Mr. G? 1. Morphine 10mg SL q4hrs prn pain 2. Morphine 3mg IV q4hrs prn pain 3. Oxycodone liquid 7.5mg poq4hrs prn pain 4. Hydromorphone 0.5mg IV q4hrs prn pain 25% 25% 25% 25%
25 Narcotic Conversions Breakthrough dose = 10% of total daily dose 150 mg/day x 2/3 = 100 mg/day morphine (10% for break through = 10 mg morphine)
26 Narcotic Equianalgesic Doses Drug PO IV Morphine 30 mg 10 mg Oxycodone 20 mg --- Hydromorphone 7.5 mg 1.5 mg Hydrocodone 30 mg mg morphine po 0.5 mg hydromorphone IV 1.5 mg hydromorphone IV = X 30mg MS PO 10mg MS PO
27 Narcotic Conversions Breakthrough dose = 10% of total daily dose Decrease total daily dose by 1/3 rd to half for incomplete cross tolerance when changing narcotics (Avoid morphine in renal and/or liver failure)
28 Narcotic Conversions Morphine ER 60 mg po q 12hr + morphine IR two 15 mg tabs/day = 120 mg + 30 mg = 150 mg total/day Decrease dose by 1/3 rd to half for incomplete cross tolerance when changing narcotics 150 mg/day x 2/3 = 100 mg/day morphine (to convert to hydromorphone)
29 Narcotic Equianalgesic Doses Drug PO IV Morphine 30 mg 10 mg Oxycodone 20 mg --- Hydromorphone 7.5 mg 1.5 mg Hydrocodone 30 mg mg morphine po 5 mg hydromorphone IV 1.5 mg hydromorphone IV = X 30mg MS PO 100mg MS PO
30 Narcotic Conversions 100 mg morphine po 5 mg hydromorphone IV 5 mg hydromorphone IV/24hrs = 0.2 mg/hr PCA order 0.2 mg/hr continuous infusion hourly rate q6min prn breakthrough pain
31 Mr. T RN from the Medicine floor calls you on crosscover to report that Mr. T, a 25 yo male admitted last night with endocarditis, is becoming agitated, complaining of pain, and demanding METHADONE!
32 Mr. T Sign-out 25 yo gentleman Full code Longstanding heroin addiction; admitted last night with presumed endocarditis Meds vancomycin, acetaminophen NTD
33 Approach to Evaluating Patients with Opioid Withdrawal Know the signs & symptoms pupillary dilatation, lacrimation, rhinorrhea, piloerection, yawning, sneezing, anorexia, nausea, vomiting, diarrhea Peak heroin withdrawal hrs, lasts 7-10 d Peak methadone w/d hrs, last >14 d Ask about: other drugs the patient may be using illicitly history of methadone maintenance patient s wishes regarding detox or no detox during this trip to the hospital
34 Mr. T Patient denies other illicit drug use except for heroin I use 3 grams a day! He wants methadone Says he usually gets 120 mg a day when he is in the hospital
35 What order would you write for Mr. T? 1. Methadone 20mg po x1, then 5mg po q2-3hrs prn until sxs resolve 2. Methadone 120mg po qday, hold for sedation 3. Oxycodone 5-10mg po q4hrs prn withdrawal sxs 33% 33% 33% 1 2 3
36 Management of Opioid W/D in Patients Not Requesting Detox Treat or prevent acute withdrawal Otherwise medical condition may not be adequately managed Methadone starting dose Methadone 20 mg po times 1, then 5 mg po q2-3h until symptoms resolve (max 60 mg a day) Primary team can see how much methadone was used overnight and come up with qd or tid dosing regimen
37 Management of Opioid W/D in Patients Requesting Detox Treat symptoms clonidine = GI distress, diaphoresis, piloerection, muscle aches NSAIDS = muscle aches promethazine (Phenergan) = nausea hydroxyzine (Vistaril) = itching, agitation Immodium = diarrhea
38 Mr. T 10 Days Later RN calls you on crosscover to report that Mr. T is becoming agitated, complaining of pain, and demanding MORE METHADONE!
39 Mr. T Sign-out 25 yo gentleman Full code Longstanding heroin addiction; endocarditis Meds nafcillin, gentamicin, rifampin, methadone 60mg qam, acetaminophen NTD
40 Methadone in General Some meds decrease methadone level Rifampin Phenytoin, steroids, carbamazepine, some antiretrovirals Some meds increase methadone levels Amitriptyline, ketoconazole, macrolides, fluoroquinolones, SSRIs, diazepam
41 Methadone in General Long, variable half-life (up to 190hrs) In general, do not increase dose more than once every 3-4 days Always write hold for sedation Dose conversion complex involve pharmacy
42 Ms. D RN calls to report that Ms. D is having new 6/10 suprapubic pain Acetaminophen 500 mg po q4hrs prn not helping
43 Ms. D Sign-out 41 yo woman Metastatic breast cancer to brain Admitted for pain control and brain XRT Meds prednisone, morphine (recently increased), acetaminophen, antiemetic NTD
44 Some Side Effects of Opioids Urinary retention Rx: Foley, decrease opioid dose, BPH meds in men Constipation Rx: senna, docusate Rx: polyethylene glycol, MOM, lactulose, bisacodyl, enema Confusion Search for underlying causes other than opioids Myoclonus Reduce dose or change to a different opioid
45 Ms. D 3 Days Later RN calls to report that Ms. D is not arousable and RR 8
46 Ms. D Sign-out 41 yo woman DNAR/DNI Metastatic breast cancer to brain Admitted for pain control and brain XRT Meds prednisone, morphine (recently increased), acetaminophen, antiemetic NTD
47 Naloxone RR 8-12/min in resting patient is usually OK (especially if the goal of care is comfort) Be careful though in patients on chronic opioids, naloxone can precipitate withdrawal & pain If you must give naloxone to patient on chronic opioids: Dilute 1 amp (0.4mg) in 10ml of saline and give 1ml IV q5 minutes
48 Remember to Call Your Resident if You Have ANY Questions There are no badges for independence, bravery, courage
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,
OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose
OPIOID CONVERSIONS 1. Converting Short acting Long Acting (IR SR) when pain is well controlled *Use for : CHRONIC pain Pts on scheduled IR opioids pain that recurs before the next dose PP: Can use equianalgesic
Review of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics
POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped
Nurses Self Paced Learning Module on Pain Management
Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: Frenchay 0117 340 6692 Southmead 0117 323
Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010
Pain Control Aims General principles of pain control Basic pharmacokinetics Case history demo Opioids renal failure John Welsh 8/4/2010 Pain Control Morphine is gold standard treatment for moderate to
October 2012. We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely,
October 2012 he Knowledge and Attitudes Survey Regarding Pain tool can be used to assess nurses and other professionals in your setting and as a pre and post test evaluation measure for educational programs.
Pain Management. Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010
Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010 Pain Management Learning Objectives- Identify most common barriers to effective treatment of pain. Describe principles of effective
Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin
Cancer Pain Role Model Program Case Studies and Faculty Guides Wisconsin Cancer Pain Initiative Madison, Wisconsin Developed by: David Weissman, MD June L. Dahl, PhD WISCONSIN CANCER PAIN INITIATIVE CANCER
Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid?
Opioid Addiction & Methadone Maintenance Treatment Dr. Nick Wong MD, CCFP AADAC Edmonton ODP AADAC AHMB Concurrent Disorder Series September 13, 2007 1 What is Methadone? What is methadone? Synthetic opioid.
Pain Management in Palliative and Hospice Care
Pain Management in Palliative and Hospice Care Donna Butler, MSN, ANP-BC, OCN, ACHPN, FAAPM Current Status of Pain Cancer patients at EOL- 54% have pain AIDS with prognosis < 6mons- intense pain Less research
How to take your Opioid Pain Medication
How to take your Opioid Pain Medication Today your doctor gave you a prescription for medication to help relieve your pain. The pain medication is called an opioid or narcotic. Taking pain medication,
Pain Management Case Studies. Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION
Pain Management Case Studies Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION 3rd Edition David E. Weissman, MD Director, Palliative Care Program Medical College of Wisconsin
Opioids, Benzos, and Tapering, Oh My! Disclosures
Opioids, Benzos, and Tapering, Oh My! Melissa B. Weimer, DO, MCR March 10, 2016 Disclosures Dr. Weimer is a paid consultant for INFORMed and a speaker for IMPACT education. Dr. Weimer is the medical director
New England Pediatric Sickle Cell Consortium
New England Pediatric Sickle Cell Consortium Management of Acute Pain in Pediatric Patients with Sickle Cell Disease (Vaso-Occlusive Episodes) Disclaimer Statement: Hospital clinical pathways are designed
Pain management. The WHO analgesic ladder
Pain management Successful treatment requires an accurate diagnosis of the cause and a rational approach to therapy. Most pains arise by stimulation of nociceptive nerve endings; the characteristics may
NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT
NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT Opioid dependence is a devastating and frequently fatal medical condition. It is a manifestation of addictive disorder
SAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool
The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline
UNIT VIII NARCOTIC ANALGESIA
UNIT VIII NARCOTIC ANALGESIA Objective Review the definitions of Analgesic, Narcotic and Antagonistic. List characteristics of Opioid analgesics in terms of mechanism of action, indications for use and
Pain Medication Taper Regimen Time frame to taper off 30-60 days
Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more
Hospital Management of Opioid Dependence. Dependence. Disclosure. Pharmacologic Management. Methadone Utilization. Hospital Management of Opioid
Disclosure Hospital Management of Opioid Dependence Attended Buprenorphine advisory board meeting (Schering Canada) May 2007, but personal honorarium/compensation was declined Dr. Alex Chan [email protected]
PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY
AN EXAMINATION OF KNOWLEDGE IN: PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY (EPERC TEST #1) 40 QUESTIONS; MULTIPLE CHOICE; SINGLE-BEST ANSWER Supplied by: End of Life Physician Education
Opioid Analgesics. Week 19
Opioid Analgesics Week 19 Analgesic Vocabulary Analgesia Narcotic Opiate Opioid Agonist Antagonist Narcotic Analgesics Controlled substances Opioid analgesics derived from poppy Opiates include morphine,
Understanding Your Pain
Toll Free: 800-462-3636 Web: www.endo.com Understanding Your Pain This brochure was developed by Margo McCaffery, RN, MS, FAAN, and Chris Pasero, RN, MS, FAAN authors of Pain: Clinical Manual (2nd ed.
OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School
OPIOIDS Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School Rutgers New Jersey Medical School Fundamentals of Addiction Medicine Summer Series Newark, NJ July 24, 2013
Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal
Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Roger Cicala, M. D. Assistant Medical Director Tennessee Physician s Wellness Program Step 1 Don t 1 It is legal in
Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist
Case Studies: Acute pain management in patients with opioid addiction Shannon Levesque, PharmD Clinical Pharmacist Disclosure I have no financial relationships with industry to disclose Objectives Misconceptions
OPIOID NEUROTOXICITY - BACK TO BASICS. Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow
OPIOID NEUROTOXICITY - BACK TO BASICS Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow OBJECTIVES Some Cases Definitions: Including what is opioid neurotoxicity A bit of biochemistry What patients
COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE
COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE INTRODUCTION High dose sublingual buprenorphine (Subutex) tablets are available in the following strengths 0.4 mg, 2 mg, and 8 mg. Suboxone tablets,
Opioids Research to Practice
Opioids Research to Practice CRIT/FIT 2015 May 2015 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Director, Clinical Addiction Research
Naloxone treatment of opioid overdose
Naloxone treatment of opioid overdose Opioids Chemicals that act in the brain to relieve pain, often use to suppress cough, treat addiction, and provide comfort After prolonged use of opioids, increasing
Lora McGuire MS, RN Educator and Consultant [email protected]. Barriers to effective pain relief
Lora McGuire MS, RN Educator and Consultant [email protected] Barriers to effective pain relief Freedom from pain is a basic human right -WHO Pain is whatever the experiencing person says it is and exists
Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical
WITHDRAWAL OF ANALGESIA AND SEDATION
WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses
1. Which of the following would NOT be an appropriate choice for postoperative pain. C. Oral oxycodone 5 mg po every 4 to 6 hours as needed for pain
Pain Management 1 Chapter 34. Pain Management, Self-Assessment Questions 1. Which of the following would NOT be an appropriate choice for postoperative pain management in a patient dependent on opioids?
MUSC Opioid Analgesic Comparison Chart
MUSC Opioid Analgesic Comparison Chart Approved by the Pharmacy and Therapeutics Committee (February 2006, November 2009, March 2010, December 2011) Prepared by the MUSC Department of Pharmacy Services
Opioid Conversion Ratios - Guide to Practice 2013
Opioid s - Guide to Practice 2013 Released 1 st October 2013 2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the Eastern
One example: Chapman and Huygens, 1988, British Journal of Addiction
This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman
PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications
PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering
Care Guide: Cancer Pain
Care Guide: Cancer Pain Key Points: Cancer Pain Specific Pain Problems 1. Pain is defined as an independent and emotional experience associated with actual or potential tissue damage or described in terms
Opioid toxicity and alternative opioids. Palliative care fixed resource session
Opioid toxicity and alternative opioids Palliative care fixed resource session Opioid toxicity and alternative opioids - aims Know the symptoms of opioid toxicity Understand which patients are at higher
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment
Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment I ve had breast cancer treatment, and now I m having pain. Does this mean the cancer
MEDICATION ABUSE IN OLDER ADULTS
MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern
Opioids Research to Practice
Opioids Research to Practice CRIT Program May 2011 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
Weaning off your pain medicine
Weaning off your pain medicine UHN Information for patients taking opioid pain medicines Read this booklet to learn about: why you need to wean off your pain medicine how to wean off slowly how to control
Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013
Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions
Narcotic drugs used for pain treatment Version 4.3
Narcotic drugs used for pain treatment Version 4.3 Strategy to restrict the pack sizes or the type of packaging available in public pharmacies. 1. Introduction The document describing the strategy of the
Safely Discontinuing Opioid Analgesics
www.pain-topics.com Safely Discontinuing Opioid Analgesics Author: Editor: Medical Reviewer: Lee A. Kral, PharmD, BCPS Stewart B. Leavitt, MA, PhD Jeffrey Fudin, BS, PharmD, DAAPM Release Date: March 2006
Objectives. Pain Management Knowing How To Help Yourself. Patients and Family Requirements. Your Rights As A Consumer
Objectives Pain Management Knowing How To Help Yourself Jackie Carter, RN MSN CNS Become familiar with the definitions of pain Be aware of your rights to have your pain treated Become familiar with the
The ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
Considerations when Using Controlled Substances to Treat Chronic Pain
Considerations when Using Controlled Substances to Treat Chronic Pain By Mary-Beth F. Plum, Pharm.D. Impact of Chronic Pain Acute pain is the body s response to environmental dangers, and it helps protect
Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC
Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635
Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer
Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer The following information is based on the general experiences of many prostate cancer patients. Your experience may be different.
Program Assistance Letter
Program Assistance Letter DOCUMENT NUMBER: 2004-01 DATE: December 5, 2003 DOCUMENT TITLE: Use of Buprenorphine in Health Center Substance Abuse Treatment Programs TO: All Bureau of Primary Health Care
Appendix 4: Guidelines for Prescribing and Administering Drugs:
Appendix 4: Guidelines for Prescribing and Administering Drugs: A midwife may prescribe and administer the following substances in accordance with the guidelines approved by the Board. This list indicates
Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS
Update in Anaesthesia Acute pain management for opioid tolerant patients Simon Marshall and Mark Jackson* *Correspondence email: [email protected] INTRODUCTION Opioid tolerance is usually encountered
Pain, Addiction & Methadone
Pain, Addiction & Methadone A CHALLENGING INTERFACE METHADONE AND SUBOXONE OPIOID SUBSTITUTION CONFERENCE Objectives 2 Explore the interface between concurrent pain and addiction. Appreciate the challenges
Opioid Agreement for Center for Pain Management S.C.
Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these
Cancer Pain. What is Pain?
Cancer Pain What is Pain? The International Association for the Study of Pain says that pain is "an unpleasant sensory and emotional experience associated with actual or potential tissue damage." Pain
Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014
Opioid s - Guide to Practice 2013 Updated as Version 2 - November 2014 2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the
Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction
Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel
Opioid Dependence. Average Purity of Retail Heroin Street Samples in U.S
Opioid Dependence Andrew J. Saxon, M.D. University of Washington, Seattle VA Puget Sound Health Care System Average Purity of Retail Heroin Street Samples in U.S 4 35 3 25 2 15 1 5 198's 1991 2 Source:
Electronic Medical Record (EMR) Safety Results of CAH Testing. Tom Johns, PharmD Shands at the University of Florida
Electronic Medical Record (EMR) Safety Results of CAH Testing Tom Johns, PharmD Shands at the University of Florida Vendors Evaluated CPSI Healthland Cerner Test Patients Test Patient A Age: 76 y/o Sex:
Medications for chronic pain
Medications for chronic pain When it comes to treating chronic pain with medications, there are many to choose from. Different types of pain medications are used for different pain conditions. You may
PAIN RELIEF GUIDE. Tips and advice from your pharmacist.
PAIN RELIEF GUIDE Tips and advice from your pharmacist. Rite Aid Pharmacists: Your Pain Relief Managers Rite Aid is committed to providing everyday products and services that help our valued customers
SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC
SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC Learning Objectives: 1. Identify the names and reasons/circumstances for additional toxicity of SELECTED OPIATES hydromorphone DILAUDID Methadone Fentanyl/DURAGESIC
Update on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
History of Malignant Pain: Treatment with Opioids. Dr. Kathleen M. Foley Pain, Opioids, and Addiction: An Urgent Problem for Doctors and Patients
History of Malignant Pain: Treatment with Opioids Dr. Kathleen M. Foley Pain, Opioids, and Addiction: An Urgent Problem for Doctors and Patients March 5-6, 5 2007 Some of the Questions that Must be Answered
Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal
Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal Kirsten H. Ohler, Pharm.D., BCPS Clinical Assistant Professor Neonatal / Pediatric Clinical Pharmacist University of Illinois at
MODERATE SEDATION RECORD (formerly termed Conscious Sedation)
(POLICY #DOC-051) Page 1 of 6 WELLSPAN HEALTH - YORK HOSPITAL NURSING POLICY AND PROCEDURE Dates: Original Issue: September 1998 Annual Review: March 2012 Revised: March 2010 Submitted by: Brenda Artz
Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment
Opioids for Chronic Pain and Addiction Treatment Joseph Merrill M.D., M.P.H. University of Washington February 24, 2012 Outline for Today Opioids for pain treatment Trends Problems High dose prescribing
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
OPIOIDS CONVERSION GUIDELINES 2007
Opioid analgesics vary in potency, side effect and pharmacokinetic profile. Therefore the Opioid Conversion Guidelines has been developed to assist when changing opioid drug therapy. When opioid rotating
Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol
Pharmacologic Effects of Alcohol Alcohol Withdrawal Kristi Theobald, Pharm.D., BCPS Therapeutics III Fall 2003 Inhibits glutamate receptor function (NMDA receptor) Inhibits excitatory neurotransmission
Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients
Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Jennifer Kuhns, Pharm.D. Pharmacy Practice Resident Children s Hospital of Michigan **The speaker has no actual or potential
Palliative Medicine, Pain Management, and Hospice. Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine
Palliative Medicine, Pain Management, and Hospice Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine Pall-i- What??? Objectives: Provide information about Palliative Medicine
Tracy Walker, RN, BSN, CCRP Research Nurse OHSU Knight Cancer Institute. 503-346-1183 [email protected]
Tracy Walker, RN, BSN, CCRP Research Nurse OHSU Knight Cancer Institute 503-346-1183 [email protected] Exercise Questions to Keep in Mind Is there an adverse event? What is the severity? What is the relationship
Opioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians
Opioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians Phyllis A. Grauer, PharmD, CGP, CPE Clinical Pharmacist Legislation Passed Enabling Office Based Treatment
STATISTICS. Opiate Substitution Therapy for Opiate Dependence. Alan Shein, M.D.
Opiate Substitution Therapy for Opiate Dependence Alan Shein, M.D. OH #1-1 STATISTICS Prevalence of Specific Drug Abuse and Vulnerability to Develop Addictions National Household Survey and Related Surveys
Strong opioids (painkillers) in palliative care what you should know
Strong opioids (painkillers) in palliative care what you should know Patient Information Author ID: JG Leaflet Number: PC 006 Version: 1 Name of Leaflet: Strong opioids (painkillers) in palliative care
Opioid Conversion Ratios - Guide to Practice 2010
Opioid Conversion Ratios - Guide to Practice 2010 Released December 2010. 2010. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that
Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -2/11/13
Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -// What is Neonatal Abstinence Syndrome? Neonatal withdrawal after intrauterine exposure
Best Practices for Patients With Pain. Commonly Used Over the Counter (OTC) Pain Relievers 5/15/2015
Faculty Best Practices for Patients With Pain Nancy Bishop, RPh Assistant State Pharmacy Director Alabama Department of Public Health Satellite Conference and Live Webcast Wednesday, May 20, 2015 2:00
